Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Investing Activities
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Cash from Investing Activities
-¥2.2B
|
CAGR 3-Years
-184%
|
CAGR 5-Years
-159%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Investing Activities
¥581.9m
|
CAGR 3-Years
840%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Investing Activities
¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Investing Activities
-¥3.2B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash from Investing Activities
-¥1.7B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Investing Activities
-¥4.7B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.2B
CNY
Based on the financial report for Dec 31, 2022, Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Investing Activities amounts to -2.2B CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-159%
Over the last year, the Cash from Investing Activities growth was -226%. The average annual Cash from Investing Activities growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been -184% over the past three years , -159% over the past five years .